Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robyn J Barst

Showing results (91-100 of 137) with videos related to

Pageof 14
Sort By:
Journal of the American College of Cardiology|June 27, 2009
Future perspectives for the treatment of pulmonary arterial hypertensionHossein A Ghofrani, Robyn J Barst, Raymond L Benza, et al.
British Journal of Haematology|February 24, 2010
Exercise capacity and haemodynamics in patients with sickle cell disease with pulmonary hypertension treated with bosentan: results of the ASSET studiesRobyn J Barst, Kamal K Mubarak, Roberto F Machado, et al.
Circulation|December 1, 2011
A randomized, double-blind, placebo-controlled, dose-ranging study of oral sildenafil citrate in treatment-naive children with pulmonary arterial hypertensionRobyn J Barst, D Dunbar Ivy, Guillermo Gaitan, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|May 13, 2014
Long-term sildenafil added to intravenous epoprostenol in patients with pulmonary arterial hypertensionGérald Simonneau, Lewis J Rubin, Nazzareno Galiè, et al.
British Journal of Haematology|July 27, 2005
Sildenafil therapy in patients with sickle cell disease and pulmonary hypertensionRoberto F Machado, Sabrina Martyr, Gregory J Kato, et al.
Chest|July 16, 2008
Sitaxsentan for the treatment of pulmonary arterial hypertension: a 1-year, prospective, open-label observation of outcome and survivalRaymond L Benza, Robyn J Barst, Nazzareno Galie, et al.
Turk Kardiyoloji Dernegi Arsivi : Turk Kardiyoloji Derneginin Yayin Organidir|February 21, 2015
[New trial designs and potential therapies for pulmonary artery hypertension]Mardi Gomberg-Maitland, Todd M Bull, Rajeev Saggar, et al.
Annals of Internal Medicine|October 22, 2008
Addition of sildenafil to long-term intravenous epoprostenol therapy in patients with pulmonary arterial hypertension: a randomized trialGérald Simonneau, Lewis J Rubin, Nazzareno Galiè, et al.
Journal of the American College of Cardiology|December 21, 2013
New trial designs and potential therapies for pulmonary artery hypertensionMardi Gomberg-Maitland, Todd M Bull, Rajeev Saggar, et al.
Blood|August 7, 2010
Pulmonary hypertension and NO in sickle cellMark T Gladwin, Robyn J Barst, Oswaldo L Castro, et al.
Pageof 14

Showing results (91-100 of 137) with videos related to

Sort By:
Pageof 14
Journal of the American College of Cardiology|June 27, 2009
Future perspectives for the treatment of pulmonary arterial hypertensionHossein A Ghofrani, Robyn J Barst, Raymond L Benza, et al.
British Journal of Haematology|February 24, 2010
Exercise capacity and haemodynamics in patients with sickle cell disease with pulmonary hypertension treated with bosentan: results of the ASSET studiesRobyn J Barst, Kamal K Mubarak, Roberto F Machado, et al.
Circulation|December 1, 2011
A randomized, double-blind, placebo-controlled, dose-ranging study of oral sildenafil citrate in treatment-naive children with pulmonary arterial hypertensionRobyn J Barst, D Dunbar Ivy, Guillermo Gaitan, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|May 13, 2014
Long-term sildenafil added to intravenous epoprostenol in patients with pulmonary arterial hypertensionGérald Simonneau, Lewis J Rubin, Nazzareno Galiè, et al.
British Journal of Haematology|July 27, 2005
Sildenafil therapy in patients with sickle cell disease and pulmonary hypertensionRoberto F Machado, Sabrina Martyr, Gregory J Kato, et al.
Chest|July 16, 2008
Sitaxsentan for the treatment of pulmonary arterial hypertension: a 1-year, prospective, open-label observation of outcome and survivalRaymond L Benza, Robyn J Barst, Nazzareno Galie, et al.
Turk Kardiyoloji Dernegi Arsivi : Turk Kardiyoloji Derneginin Yayin Organidir|February 21, 2015
[New trial designs and potential therapies for pulmonary artery hypertension]Mardi Gomberg-Maitland, Todd M Bull, Rajeev Saggar, et al.
Annals of Internal Medicine|October 22, 2008
Addition of sildenafil to long-term intravenous epoprostenol therapy in patients with pulmonary arterial hypertension: a randomized trialGérald Simonneau, Lewis J Rubin, Nazzareno Galiè, et al.
Journal of the American College of Cardiology|December 21, 2013
New trial designs and potential therapies for pulmonary artery hypertensionMardi Gomberg-Maitland, Todd M Bull, Rajeev Saggar, et al.
Blood|August 7, 2010
Pulmonary hypertension and NO in sickle cellMark T Gladwin, Robyn J Barst, Oswaldo L Castro, et al.
Pageof 14